Saad Mark E 4
4 · Axsome Therapeutics, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-03+16,976→ 16,976 totalExercise: $25.53From: 2023-06-03Exp: 2032-06-03→ Common Stock (16,976 underlying)
Footnotes (1)
- [F1]The option vests in full on the one-year anniversary of the date of grant, June 3, 2023.